These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

63 related articles for article (PubMed ID: 11764861)

  • 21. The role of glimepiride in the effective management of Type 2 diabetes.
    Davis SN
    J Diabetes Complications; 2004; 18(6):367-76. PubMed ID: 15531188
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Homeostasis model assessment (HOMA) as surrogate insulinization criteria in patients with type 2 diabetes.
    Bermúdez V; Cano R; Cano C; Bermúdez F; Leal E; Acosta K; Mengual E; Arraiz N; Briceño C; Gómez J; Bustamante M; Aparicio D; Cabrera M; Valdelamar L; Rodriguez M; Manuel V; Hernández R
    Am J Ther; 2008; 15(4):409-16. PubMed ID: 18645347
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Practical ambulatory therapy for multisystem atrophy and diabetes mellitus].
    Fassbender WJ
    Dtsch Med Wochenschr; 2005 Oct; 130(41):2347-8. PubMed ID: 16231237
    [No Abstract]   [Full Text] [Related]  

  • 24. Follow-up of intensive glucose control in type 2 diabetes.
    Mühlhauser I
    N Engl J Med; 2009 Jan; 360(4):417; author reply 418. PubMed ID: 19172674
    [No Abstract]   [Full Text] [Related]  

  • 25. Why insulin sensitizers but not secretagogues should be retained when initiating insulin in type 2 diabetes.
    Raskin P
    Diabetes Metab Res Rev; 2008; 24(1):3-13. PubMed ID: 17968971
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Glimepiride in daily practice].
    Jasik M
    Przegl Lek; 2003; 60(6):409-12. PubMed ID: 14974179
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A case of new mutation in maturity-onset diabetes of the young type 3 (MODY 3) responsive to a low dose of sulphonylurea.
    Jesić MD; Sajić S; Jesić MM; Maringa M; Micić D; Necić S
    Diabetes Res Clin Pract; 2008 Jul; 81(1):e1-3. PubMed ID: 18433912
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Relationship between antidiabetic treatment with QT dispersion during acute coronary syndromes in type 2 diabetes: comparison between patients receiving sulfonylureas and insulin.
    Tentolouris N; Matsagura M; Psallas M; Chatzizacharias A; Fotia M; Arvanitis M; Katsilambros N
    Exp Clin Endocrinol Diabetes; 2005 May; 113(5):298-301. PubMed ID: 15926117
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Comparison of lipid profiles and lipoprotein a levels in patients with type 2 diabetes mellitus during oral hypoglycemic or insulin therapy.
    Habib SS; Aslam M; Naveed AK; Razi MS
    Saudi Med J; 2006 Feb; 27(2):174-80. PubMed ID: 16501671
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Long-term pioglitazone therapy improves arterial stiffness in patients with type 2 diabetes mellitus.
    Harashima K; Hayashi J; Miwa T; Tsunoda T
    Metabolism; 2009 Jun; 58(6):739-45. PubMed ID: 19446110
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Some thoughts on the treatment of non-insulin-dependent diabetes mellitus.
    Somers G; Keymeulen B; Segers O
    Acta Clin Belg; 1993; 48(4):221-7. PubMed ID: 8212973
    [No Abstract]   [Full Text] [Related]  

  • 32. Management of noninsulin-dependent diabetes mellitus.
    Zimmerman BR; Service FJ
    Med Clin North Am; 1988 Nov; 72(6):1355-64. PubMed ID: 3054357
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Treatment of type II diabetes.
    Nattrass M
    Br Med J (Clin Res Ed); 1986 Apr; 292(6527):1033-4. PubMed ID: 3083989
    [No Abstract]   [Full Text] [Related]  

  • 34. Type II diabetes mellitus: a treatment dilemma. Introduction.
    Lebovitz HE
    Am J Med; 1987 Sep; 83(3A):1-2. PubMed ID: 3115100
    [No Abstract]   [Full Text] [Related]  

  • 35. Insulin for the non-insulin dependent?
    Holman RR
    Br Med J (Clin Res Ed); 1988 May; 296(6634):1469-70. PubMed ID: 3132300
    [No Abstract]   [Full Text] [Related]  

  • 36. Insulin for the non-insulin dependent?
    Taylor R
    Br Med J (Clin Res Ed); 1988 Apr; 296(6628):1015-6. PubMed ID: 3130118
    [No Abstract]   [Full Text] [Related]  

  • 37. Effective factors in controlling diabetes progression among patients in the northwest of Iran.
    Asgharzadeh M; Pourasghary S; Pourasghary B; Nourazarian M; Kafil HS
    J Nat Sci Biol Med; 2016; 7(1):68-71. PubMed ID: 27003973
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Combination therapy for type 2 diabetes.
    Bell DS
    Am Fam Physician; 2001 Dec; 64(11):1812, 1814. PubMed ID: 11764861
    [No Abstract]   [Full Text] [Related]  

  • 39. Combination sulfonylurea-insulin therapy in the treatment of noninsulin-dependent diabetes mellitus.
    Rosenblatt J
    Conn Med; 1991 Nov; 55(11):634-6. PubMed ID: 1790695
    [No Abstract]   [Full Text] [Related]  

  • 40. [Combination therapy insulin and sulfonylurea compounds. A critical analysis].
    Ratzmann KP; Berger M
    Z Arztl Fortbild (Jena); 1990; 84(21):1105-7. PubMed ID: 2281698
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.